Vanguard Group Inc Poseida Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,663,456 shares of PSTX stock, worth $34.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,663,456

Previous 3,405,805 7.57%

Holding current value

$34.6 Million

Previous $9.94 Million 5.36%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.7 - $4.04 $695,657 - $1.04 Million	257,651 Added 7.57%	3,663,456 $10.5 Million
Q2 2024 Aug 13, 2024	BUY	$2.0 - $3.46 $65,480 - $113,280	32,740 Added 0.97%	3,405,805 $9.94 Million
Q1 2024 May 10, 2024	BUY	$2.76 - $4.13 $1.31 Million - $1.96 Million	473,746 Added 16.34%	3,373,065 $10.8 Million
Q4 2023 Feb 14, 2024	BUY	$1.83 - $3.51 $477,382 - $915,636	260,865 Added 9.89%	2,899,319 $9.74 Million
Q3 2023 Nov 14, 2023	BUY	$1.62 - $2.79 $76,553 - $131,841	47,255 Added 1.82%	2,638,454 $6.28 Million
Q2 2023 Aug 14, 2023	BUY	$1.66 - $3.4 $382,542 - $783,519	230,447 Added 9.76%	2,591,199 $4.56 Million
Q1 2023 May 15, 2023	BUY	$3.08 - $8.73 $90,693 - $257,063	29,446 Added 1.26%	2,360,752 $7.27 Million
Q4 2022 Feb 10, 2023	SELL	$3.33 - $6.38 $178,354 - $341,712	-53,560 Reduced 2.25%	2,331,306 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$2.43 - $4.51 $2.57 Million - $4.78 Million	1,059,216 Added 79.9%	2,384,866 $8.42 Million
Q2 2022 Aug 12, 2022	SELL	$1.87 - $5.0 $225,548 - $603,070	-120,614 Reduced 8.34%	1,325,650 $3.42 Million
Q1 2022 May 13, 2022	SELL	$3.22 - $7.04 $18,969 - $41,472	-5,891 Reduced 0.41%	1,446,264 $6.48 Million
Q4 2021 Feb 14, 2022	SELL	$6.23 - $7.6 $392,732 - $479,096	-63,039 Reduced 4.16%	1,452,155 $9.89 Million
Q3 2021 Nov 12, 2021	BUY	$7.09 - $10.71 $1.31 Million - $1.98 Million	184,743 Added 13.89%	1,515,194 $11 Million
Q2 2021 Aug 13, 2021	BUY	$7.96 - $10.07 $10.6 Million - $13.4 Million	1,330,451 New	1,330,451 $13.3 Million

Others Institutions Holding PSTX

# of Institutions

Shares Held

38.5M

Call Options Held

377K

Put Options Held

22.2K

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $811M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Poseida Therapeutics, Inc. Transaction History